Under construction – not a live service
Sign in
Not yet taking people in RomaniaPhase 1

Tests DF-006 pill for safety in healthy adults and chronic hepatitis B

Tests a new oral drug, DF-006, for safety in healthy adults and hepatitis B patients.

Key facts

Who runs it
Zhejiang Yaoyuan Biotechnology Co. Ltd.
Where
Cluj-Napoca, RomaniaSee the siteAlso in 1 other country, 1 site
Registry title
A Phase 1, Double-blind, Randomized, Placebo-controlled, First-in-Human Study of Orally Administered DF-006 to Evaluate the Safety, Tolerability, and Pharmacokinetics After a Single Dose and Multiple Doses of Orally Administered DF-006 in Healthy Subjects (Part 1 and Part 2) and in Chronic Hepatitis B Patients (Part 3). Protocol Number Df-006-1001
Status
Not yet recruiting
Phase
Phase 1
People taking part
12 people, planned
Started
26 Feb 2024
Planned end
30 Sept 2024
Type of study
Interventional
Record updated
17 April 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for healthy adults (Parts 1 and 2) and adults with chronic hepatitis B (Part 3) to test the safety of an oral drug called DF-006.

Age
18 to 64 years
Sex
Women and men can join.
Disease stage
Chronic hepatitis B for Part 3. Parts 1 and 2 are for healthy people.

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where in Romania

Also in 1 other country, 1 site

  • Spitalul Clinic Judetean De Urgenta ClujCluj-Napoca, RomaniaNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Tests DF-006 pill for safety in healthy adults and chronic hepatitis BGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Fit questions
Built from 2023-504288-18-00, who can take part
Record updated
17 April 2024